↓ Skip to main content

Expanding anti-CD38 immunotherapy for lymphoid malignancies

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, June 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Expanding anti-CD38 immunotherapy for lymphoid malignancies
Published in
Journal of Experimental & Clinical Cancer Research, June 2022
DOI 10.1186/s13046-022-02421-2
Pubmed ID
Authors

Xu Wang, Xinfang Yu, Wei Li, Praveen Neeli, Ming Liu, Ling Li, Mingzhi Zhang, Xiaosheng Fang, Ken H. Young, Yong Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 17%
Student > Master 3 13%
Researcher 3 13%
Student > Ph. D. Student 2 9%
Lecturer 1 4%
Other 1 4%
Unknown 9 39%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 26%
Medicine and Dentistry 5 22%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Business, Management and Accounting 1 4%
Chemistry 1 4%
Other 0 0%
Unknown 9 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 July 2022.
All research outputs
#14,402,752
of 25,392,582 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#753
of 2,383 outputs
Outputs of similar age
#176,630
of 441,673 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#23
of 63 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,383 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,673 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.